EUVIMEDEUVIMED entdecken
Crossref

GLP ‐1 receptor agonist liraglutide alleviates kidney injury by regulating nuclear translocation of NRF2 in diabetic nephropathy

Tingting Lin, Yuze Zhang, Qifeng Wei, Zugui Huang

Clinical and Experimental Pharmacology and Physiology · 2024

DOI: 10.1111/1440-1681.70003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, 2024. Verfasst von Tingting Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, Fujian, China. Hauptthemen laut MEDLINE: Liraglutide, NF-E2-Related Factor 2, Diabetic Nephropathies, Glucagon-Like Peptide-1 Receptor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Fujian Provincial Natural Science Foundation of China, Startup Fund for scientific research of Fujian Medical University, Scientific and Technological Major Special Project of Fujian Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic nephropathy (DN) is a severe renal disorder that arises as a complication of diabetes. Liraglutide, an analogue of a glucagon‐like peptide 1 (GLP‐1) receptor agonist, has been shown to decrease diabetes‐caused renal damage. Nevertheless, the complete understanding of the roles and mechanism remains unclear. In our study, diabetic rat models were created through a single intraperitoneal injection of streptozotocin (STZ). The level of fasting blood glucose, 24‐h urine protein, serum creatinine (Scr) and blood urea nitrogen (BUN) were assessed. Periodic acid‐Schiff (PAS) staining was applied to examine the pathological changes in renal tissues. Reactive oxygen species (ROS) formation was measured via dichloro‐dihydro‐fluorescein diacetate (DCFH‐DA) probes. Western blot was conducted to examine the levels of oxidative stress‐related and extracellular matrix (ECM)‐associated proteins. The nuclear translocation of NRF2 was investigated through immunofluorescence and Western blot assays. We demonstrated that liraglutide attenuated DN‐induced oxidative stress and ECM deposition in vitro and in vivo. Liraglutide exerted a reno‐protective effect by promoting nuclear translocation of NRF2 in mesangial cells. ML385, an NRF2 inhibitor, counteracted the beneficial impact of liraglutide.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiraglutideNF-E2-Related Factor 2Diabetic NephropathiesGlucagon-Like Peptide-1 ReceptorGlucagon-Like Peptide-1 Receptor AgonistsAnimalsRatsMaleOxidative StressRats, Sprague-DawleyCell NucleusReactive Oxygen SpeciesKidneyDiabetes Mellitus, Experimental

Stichwörter der Autor:innen

ECMNRF2diabetic nephropathyliraglutideoxidative stress

Substanzen

LiraglutideNF-E2-Related Factor 2Glucagon-Like Peptide-1 ReceptorNfe2l2 protein, ratReactive Oxygen SpeciesGlucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, Fujian, China.
  • Department of Cardiovascular Medicine, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, Fujian, China.

Förderung

  • Fujian Provincial Natural Science Foundation of China
  • Startup Fund for scientific research of Fujian Medical University
  • Scientific and Technological Major Special Project of Fujian Provincial Health Commission

Zitieren

APA

Lin, T., Zhang, Y., Wei, Q., & Huang, Z. (2024). GLP ‐1 receptor agonist liraglutide alleviates kidney injury by regulating nuclear translocation of NRF2 in diabetic nephropathy. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/1440-1681.70003

Vancouver

Lin T, Zhang Y, Wei Q, Huang Z. GLP ‐1 receptor agonist liraglutide alleviates kidney injury by regulating nuclear translocation of NRF2 in diabetic nephropathy. Clinical and Experimental Pharmacology and Physiology. 2024. doi:10.1111/1440-1681.70003

BibTeX
@article{Lin2024,
  author = {Lin, Tingting and Zhang, Yuze and Wei, Qifeng and Huang, Zugui},
  title = {GLP ‐1 receptor agonist liraglutide alleviates kidney injury by regulating nuclear translocation of NRF2 in diabetic nephropathy},
  journal = {Clinical and Experimental Pharmacology and Physiology},
  year = {2024},
  doi = {10.1111/1440-1681.70003}
}
Kostenlos starten →